Why This Oddity Tech Stock Is Up 7% Today: Buyback Signals
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
Warning Signs Of Inadequate Retirement Planning
Inadequate retirement planning can jeopardize your future. Learn to spot the warning signs to ensure your retirement is secure.
15,144 articles
Uber's Partnership with Amazon's: A Game-Changer for Investors
A new collaboration between Uber and Amazon's Zoox signals more than tech sharing. This alliance could redefine the e...
Leveraged Showdown: SOXL's Semiconductor or SPXL's Stability
Two popular 3x ETFs chase daily moves in different corners of the market. This guide breaks down when levered bets on...
Walmart Metric Watch 2026: Key Indicators for Investors
In 2026, investors are focusing on profits, not just sales. This guide explains the walmart metric watch 2026 framewo...
Keeping Your Makes Richer: Job Stability in Real Estate
Staying employed isn’t just about paychecks—it’s a powerful lever for real estate wealth. This guide shows how job st...
Bahrain Starts Output Cuts at World’s Top Aluminum Smelter
Aluminium Bahrain B.S.C. (Alba) has begun a phased shutdown of three production lines, slashing about 19% of its capa...
Amazon Looking to Reignite Growth with One Bold Move
Amazon plans to move Prime Day earlier this summer, aiming to boost Q2 results and reframe the competitive promo cale...
Waterbridge (WBI) 2025 Earnings: Comprehensive Stock Insight
Waterbridge's 2025 earnings narrative offers insight into growth drivers, cash flow, and capital allocation. This ana...
Clark Howard’s Verdict on a $300,000 Inherited Home Sparks Debate
Two brothers inherit a Colorado home valued at $300,000 with a $100,000 mortgage. One wants cash, the other to stay. ...
Defense Stocks Rise Iran: What Investors Need to Know
Geopolitical tensions involving Iran can shift the defense landscape fast. This guide explains how to spot potential ...
This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
AtriCure Sells 5,000 Shares: Insider Move or Pattern Worth Watching?
A senior executive at AtriCure recently sold 5,000 shares, prompting questions about what this insider move means for...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status